AB Science communicates the results from phase 2B/3 study evaluating masitinib in Alzheimer’s disease

NEXT STORY
TLC Provides Corporate Update at Investor Conference
PREV STORY
8,242 Orion Corporation A shares converted into B shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor Models

MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or ...

author_avatar
NASDAQ Market News

Tauriga Sciences, Inc. Enters into Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.

author_avatar
NASDAQ Market News

XBiotech Wins “Commercial Real Estate Award for Industrial Development” for its Headquarters in Austin, Texas

author_avatar
NASDAQ Market News